Cite
MLA Citation
Dorothea Hanf et al.. “Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3G623R Solvent-Front Mutation.” JCO precision oncology, vol. 5, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100150611398.0x000009